Drug Metabolism and Pharmacogenetics in Personalized Medicine
American Journal Of Pharmacy And Pharmacology · 30.06.2023 · 4 (3) · 11-15
DOI: 10.71465/ajpp.2697 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal Of Pharmacy And Pharmacology, online erschienen am 30.06.2023. Verfasst von Dr. Michael Lewis.
Abstract (Originalsprache)
Personalized medicine aims to tailor drug therapy based on individual genetic profiles to improve efficacy and minimize adverse effects. A key component of personalized medicine is the understanding of drug metabolism and pharmacogenetics, which involve genetic variations that affect drug absorption, distribution, metabolism, and excretion. This article explores the role of pharmacogenetics in drug metabolism and its application in personalized medicine. We discuss how genetic polymorphisms in drug-metabolizing enzymes, transporters, and receptors influence drug responses and the potential for optimizing drug therapy based on genetic testing .
Zitieren
APA
Lewis, D. M. (2023). Drug Metabolism and Pharmacogenetics in Personalized Medicine. American Journal Of Pharmacy And Pharmacology, 4(3), 11-15. https://doi.org/10.71465/ajpp.2697
Vancouver
Lewis DM. Drug Metabolism and Pharmacogenetics in Personalized Medicine. American Journal Of Pharmacy And Pharmacology. 2023;4(3):11-15. doi:10.71465/ajpp.2697
BibTeX
@article{Lewis2023,
author = {Lewis, Dr. Michael},
title = {Drug Metabolism and Pharmacogenetics in Personalized Medicine},
journal = {American Journal Of Pharmacy And Pharmacology},
year = {2023},
volume = {4},
number = {3},
pages = {11--15},
doi = {10.71465/ajpp.2697}
}
EUVIMED